JNJ 17029259
JNJ 17029259 is an orally active and selective VEGF-R2 kinase inhibitor. JNJ 17029259 inhibits VEGF-mediated signal transduction. JNJ 17029259 has anti-angiogenic activity.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 314267-57-7
- Fòrmula: C26H30N6O
- Peso molecular:442.56
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas VEGFR
More
Actividad biológica
Chemical Information
-
No. CAS 314267-57-7
-
Peso molecular 442.56
-
Fòrmula C26H30N6O
-
SMILES
CC(C)(N)C(C=C1)=CC=C1C2=NC(NC3=CC=C(CCN4CCOCC4)C=C3)=NC=C2C#N
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)